Sun Pharmaceutical Industries Share Price
Large Cap | Pharmaceuticals and health care | NSE: SUNPHARMA | BSE: 524715
₹1,673.60 
7.25 (0.44 %)
Last Updated: 08 Apr 2025 10:49 AM
BEARISH
Overview
Open (₹) 1,645.00
High (₹) 1,691.45
Low (₹) 1,645.00
Prev. Close (₹) 1,666.35
Volume 7,95,542
VWAP (₹) 1,609.13
ROCE (%) 17.26
Industry P/E 43.36
TTM P/E 35.09
P/B Ratio 5.98
Market Cap (₹) Cr.4,01,552.70
Dividend Yield (%)0.81
EPS (₹) 39.90
ROE14.27%
Sales Growth (%) 10.51
Profit Growth (%)12.70
Day Range
1,691.451,691.45
52 Week Range
1,376.751,960.20
Historical Returns
Returns (6M)
-11.34 %
Returns (1Y)
4.62 %
Returns (3Y)
80.85 %
Returns (5Y)
268.27 %
Returns (6M)
-11.34 %
Returns (1Y)
4.62 %
Returns (3Y)
80.85 %
Returns (5Y)
268.27 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (13.03%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 13.03% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 58.85
MFI 23.75
ATR 44.62
Commodity Channel Index -142.23
ROC125 -11.45
ROC21 -8.39
Williams %R -95.88
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,647.36 | 1,701.48 | 1,731.96 | 1,616.88 | 1,562.76 | 1,532.28 | 1,478.16 |
| Week Ago | 1,674.76 | 1,705.78 | 1,727.16 | 1,653.38 | 1,622.36 | 1,600.98 | 1,569.96 |
| Month Ago | 1,759.30 | 1,813.10 | 1,846.20 | 1,726.20 | 1,672.40 | 1,639.30 | 1,585.50 |
EMA & SMA
1673.60
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
13
5 Day 1632.93
9 Day 1667.22
10 Day 1667.35
12 Day 1676.21
14 Day 1683.97
20 Day 1702.41
26 Day 1719.64
50 Day 1765.28
100 Day 1799.07
200 Day 1728.18
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SOCIETE GENERALE | block | Sell | 25 Jan, 2024 | ₹1,382.10 | 1,30,898 | NSE |
| MARSHALL WACE INVESTMENT STRATEGIES TOPS FUND | block | Buy | 25 Jan, 2024 | ₹1,382.10 | 3,160 | NSE |
| MARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND | block | Buy | 25 Jan, 2024 | ₹1,382.10 | 1,27,712 | NSE |
| MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND | block | Buy | 25 Jan, 2024 | ₹1,382.10 | 26 | NSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 14 Nov, 2022 | ₹1,013.55 | 14,04,266 | NSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 14 Nov, 2022 | ₹1,013.55 | 14,04,266 | NSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Nov, 2022 | ₹1,051.95 | 14,04,266 | NSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Nov, 2022 | ₹1,051.95 | 14,04,266 | NSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 25 Oct, 2022 | ₹987.00 | 7,55,497 | NSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 25 Oct, 2022 | ₹987.00 | 7,55,497 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 29 Sept, 2023 | Raksha Valia Revised | Pledge | ₹1,117.00 | 20,20,000 | NSE |
| 29 Sept, 2023 | Raksha Valia Revised | Pledge | ₹937.45 | 10,00,000 | NSE |
| 30 Aug, 2023 | Raksha Valia-Person Acting in Concert and immediate relative of Non Executive Non Independent Director Member of Promoter Group | Pledge | ₹1,117.00 | 20,20,000 | NSE |
| 30 May, 2023 | Raksha Valia-Person Acting in Concert and immediate relative of Non Executive Non Independent Director Member of Promoter Group Revised | Pledge | ₹961.20 | 16,50,000 | NSE |
| 30 May, 2023 | Raksha Valia-Person Acting in Concert and immediate relative of Non Executive Non Independent Director Member of Promoter Group Revised | Pledge | ₹968.55 | 24,20,000 | NSE |
| 30 May, 2023 | Raksha Valia-Person Acting in Concert and immediate relative of Non Executive Non Independent Director Member of Promoter Group Revised | Pledge | ₹968.55 | 11,90,000 | NSE |
| 30 May, 2023 | Shanghvi Finance Private Limited Member of Promoter Group Revised | Revoke | ₹965.25 | 1,19,837 | NSE |
| 30 May, 2023 | Raksha Valia-Person Acting in Concert and immediate relative of Non Executive Non Independent Director Member of Promoter Group Revised | Pledge | ₹966.90 | 11,60,000 | NSE |
| 30 May, 2023 | Raksha Valia-Person Acting in Concert and immediate relative of Non Executive Non Independent Director Member of Promoter Group Revised | Revoke | ₹959.30 | 81,01,000 | NSE |
| 23 May, 2023 | Raksha Valia-Person Acting in Concert and immediate relative of Non Executive Non Independent Director Member of Promoter Group | Pledge | ₹937.45 | 10,00,000 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 16 Jan, 2025 | Rs.10.5000 per share(1050%)Interim Dividend | 06 Feb, 2025 | 06 Feb, 2025 |
| 22 May, 2024 | Rs.5.0000 per share(500%)Final Dividend | 12 Jul, 2024 | 12 Jul, 2024 |
| 15 Jan, 2024 | Rs.8.5000 per share(850%)Interim Dividend | 09 Feb, 2024 | 09 Feb, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 07 Apr, 2025 | BSE India | Sun Pharma introduces a novel class of drug, Fexuclue (Fexuprazan) in India. |
| 31 Mar, 2025 | NSE India | SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 31 Mar, 2025 | NSE India | Sun Pharmaceutical Industries Limited has informed the Exchange about the Change in the Board of Directors and the Audit Committee |
| 31 Mar, 2025 | BSE India | Change in Board of Directors and Audit Committee |
| 26 Mar, 2025 | BSE India | Update on our Investee Company |
| 26 Mar, 2025 | NSE India | Sun Pharmaceutical Industries Limited has informed the Exchange about Updates on our Investee Company |
| 25 Mar, 2025 | NSE India | Sun Pharmaceutical Industries Limited has informed the Exchange about Closure of Trading Window |
| 25 Mar, 2025 | NSE India | Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 18 Mar, 2025 | NSE India | Sun Pharmaceutical Industries Limited has informed the Exchange about update on acquisition |
| 18 Mar, 2025 | BSE India | Intimation regarding Completion of 100% Acquisition in Antibe Therapeutics Inc. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Interim Dividend | -- | 17 Jan, 2025 | 31 Jan, 2025 |
| Quarterly Results | -- | 10 Oct, 2024 | 28 Oct, 2024 |
| Quarterly Results | -- | 16 Jul, 2024 | 01 Aug, 2024 |
| Audited Results & Final Dividend | -- | 30 May, 2024 | 22 May, 2024 |
| Quarterly Results & Interim Dividend | -- | 30 May, 2024 | 31 Jan, 2024 |
| Quarterly Results | -- | 30 May, 2024 | 01 Nov, 2023 |
| Quarterly Results | -- | 30 May, 2024 | 03 Aug, 2023 |
| Audited Results & Final Dividend | -- | 30 May, 2024 | 26 May, 2023 |
| Quarterly Results & Interim Dividend | -- | 30 May, 2024 | 31 Jan, 2023 |
| Quarterly Results | -- | 30 May, 2024 | 01 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 54.48% | 54.48% | 54.48% | 54.48% | 54.48% |
| Foreign Institutions + | 18.04% | 17.08% | 16.87% | 13% | 12.19% |
| Domestic Institutions + | 18.54% | 19.53% | 19.14% | 21% | 20.84% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 8.94% | 8.91% | 9.51% | 11.52% | 12.49% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Sun Pharmaceutical Industries
Sun Pharmaceutical Industries is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 20275.17 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Dilip S Shanghvi
NSE Symbol
SUNPHARMA
Sun Pharmaceutical Industries Management
| Name | Designation |
|---|---|
| Mr. Dilip S Shanghvi | Chairman & Managing Director |
| Mr. Aalok D Shanghvi | Whole Time Director |
| Mr. Sudhir V Valia | Non Exe.Non Ind.Director |
| Dr. Pawan Goenka | Lead Independent Director |
| Mr. Rama Bijapurkar | Independent Director |
| Mr. Gautam Doshi | Independent Director |
| Mr. Sanjay Asher | Independent Director |
| Mr. Rolf Hoffmann | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹3,99,813.18 | ₹1,673.60  ₹1,666.35(0.44%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,39,608.60 | ₹5,394.90 ₹5,258.95(2.59%) | ₹3,640.100 - ₹6,448.750 |
| Cipla | ₹1,11,830.74 | ₹1,399.35 ₹1,384.70(1.06%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,09,438.03 | ₹3,193.45  ₹3,233.55(-1.24%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹98,336.03 | ₹2,384.05 ₹2,383.45(0.03%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Sun Pharmaceutical Industries
What is the share price of Sun Pharmaceutical Industries?
The share price of Sun Pharmaceutical Industries on 08 Apr, 2025 is ₹ 1,673.60.
What is 52W high and 52W low share price of Sun Pharmaceutical Industries?
The highest and lowest 52W share prices of Sun Pharmaceutical Industries are ₹ 1960.200 and ₹ 1376.750
What is the market cap of Sun Pharmaceutical Industries?
The market capitalization of Sun Pharmaceutical Industries as of 08 Apr, 2025 is ₹ 4,01,552.70 Crores
What is the P/E ratio of Sun Pharmaceutical Industries?
The current P/E ratio of Sun Pharmaceutical Industries as of 08 Apr, 2025 is 43.36
What is the PB ratio of Sun Pharmaceutical Industries?
The PB ratio of Sun Pharmaceutical Industries as of 08 Apr, 2025 is 5.98
Top Gainers
₹67.00
₹56.11 (0.19%)
₹64.50
₹55.00 (0.17%)
₹30.18
₹25.15 (0.20%)
₹33.41
₹27.96 (0.19%)
Top Losers
₹20.60
₹24.76 (-0.17%)
₹6.40
₹7.52 (-0.15%)
₹2,814.65
₹4,939.80 (-0.43%)
₹75.12
₹89.69 (-0.16%)
Market Indices
Sensex
₹73,137.90
₹75,364.69 (-0.03%)